Life with MASH: Long-Term Monitoring and Heart Health

Managing MASH is a long-term journey of monitoring and protection. Because the liver can heal or scar slowly over years, your care team will use regular “check-points” to ensure your treatment is working and to catch any complications early ^[1].

While it is natural to feel anxious about regular testing—sometimes called “scan anxiety”—these tools are your best defense. They allow you to stay ahead of the disease rather than reacting to symptoms.

Protecting Your Heart: The Priority

It may be surprising to learn that for most people with MASLD and MASH, a major and often leading competing risk to health is not liver failure, but cardiovascular disease (heart attack or stroke) ^[2][3].

The same metabolic factors that cause fat to build up in your liver—like insulin resistance and high cholesterol—also cause plaque to build up in your arteries ^[4]. Because of this, “liver care” is actually “heart care.”

• Comprehensive Monitoring: Your doctor will closely monitor your blood pressure, LDL cholesterol, and blood sugar (HbA1c) as part of your MASH management ^[1][5].
• Statins: These cholesterol-lowering medications are generally safe for people with MASH and provide vital protection for your heart ^[4].

Long-Term Liver Monitoring

The frequency of your check-ups depends on how much scarring (fibrosis) was found during your diagnosis, the number of metabolic risk factors you have, and your clinician’s plan.

Monitoring Noncirrhotic MASH (Stages F0–F3)

If you do not have cirrhosis, the goal is to watch for any sign that the disease is progressing.

• Variable Intervals: Testing frequency depends on diabetes, metabolic risk factors, baseline risk, test availability, and specialist judgment. For many stable patients, non-invasive tests like FIB-4 or FibroScan may be repeated every 1 to 3 years ^[1].
• Treatment Monitoring: If you have started a new treatment, such as resmetirom (Rezdiffra), safety laboratory monitoring (such as liver tests, thyroid-related tests, lipids, and medication review) will be done more frequently. Note that changes in FibroScan do not reliably measure histologic treatment response over a short period.

Surveillance for Cirrhosis (Stage F4)

If you have advanced scarring (cirrhosis), the liver needs a more intensive level of surveillance to watch for specific complications ^[1].

• Liver Cancer (HCC) Screening: You will likely need an ultrasound of your liver every 6 months ^[6][7]. Your doctor may also check a blood marker called AFP (alpha-fetoprotein) to increase the accuracy of the screening ^[8][9]. If ultrasound quality is limited by body habitus, MRI or multiphasic CT may be required. Routine HCC surveillance is generally focused on cirrhosis, though decisions for F3 disease can vary by guideline and individual risk.
• Portal Hypertension: This is a condition where pressure builds up in the veins leading to the liver. Noninvasive platelet/liver-stiffness criteria and the use of portal-hypertension guidance determine who needs an endoscopy (EGD) to check for enlarged veins (varices) in the esophagus, or who can safely avoid one ^[1][10].

Daily Liver Safety

Beyond scans and blood work, you protect your liver every day by being mindful of what you consume. Always direct questions to a pharmacist or clinician.

• Alcohol: Abstinence is especially important with clinically significant fibrosis, cirrhosis, or alcohol-related disease ^[1][11]. People who drink heavily or may be physically dependent should seek medical help before stopping, to ensure withdrawal safety.
• Pain Relief (Acetaminophen/Tylenol): Acetaminophen can be preferred over NSAIDs in many patients with compensated chronic liver disease when the clinician approves it. However, the safe amount depends on cirrhosis status, alcohol use, malnutrition, and other medicines. In advanced cases, it is often limited to 2 grams per day. Always check multi-symptom cold and flu medicines, as they often contain hidden acetaminophen ^[12][13]. An overdose can cause liver failure.
• NSAIDs (Ibuprofen/Naproxen): These are particularly risky if you have cirrhosis, ascites, kidney disease, or gastrointestinal bleeding, as they can increase the risk of kidney injury and internal bleeding ^[14][15]. However, you should not independently stop prescribed aspirin or other cardiovascular drugs.

By staying consistent with your individualized monitoring and being cautious with daily medications, you can manage MASH effectively and significantly reduce the risk of long-term complications ^[1].